247 related articles for article (PubMed ID: 32830857)
21. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
[TBL] [Abstract][Full Text] [Related]
22. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
Chen WQ; Yang SJ; Xu WX; Deng F; Wang DD; Tang JH
Medicine (Baltimore); 2021 Oct; 100(42):e27489. PubMed ID: 34678879
[TBL] [Abstract][Full Text] [Related]
24. EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.
Kallel I; Khabir A; Boujelbene N; Abdennadher R; Daoud J; Frikha M; Aifa S; Sallemi-Boudawara T; Rebaï A
J Recept Signal Transduct Res; 2012 Jun; 32(3):142-9. PubMed ID: 22394363
[TBL] [Abstract][Full Text] [Related]
25. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
[No Abstract] [Full Text] [Related]
26. Overexpression of HMGB3 and its prognostic value in breast cancer.
Zhou X; Zhang Q; Liang G; Liang X; Luo B
Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
[TBL] [Abstract][Full Text] [Related]
27. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y
Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141
[TBL] [Abstract][Full Text] [Related]
29. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.
Song X; Zhao C; Jiang L; Lin S; Bi J; Wei Q; Yu L; Zhao L; Wei M
Pathol Res Pract; 2018 Dec; 214(12):2046-2053. PubMed ID: 30322808
[TBL] [Abstract][Full Text] [Related]
30. Decreased PITX1 gene expression in human cutaneous malignant melanoma and its clinicopathological significance.
Osaki M; Chinen H; Yoshida Y; Ohhira T; Sunamura N; Yamamoto O; Ito H; Oshimura M; Kugoh H
Eur J Dermatol; 2013; 23(3):344-9. PubMed ID: 23816528
[TBL] [Abstract][Full Text] [Related]
31. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach.
Saindane M; Rallabandi HR; Park KS; Heil A; Nam SE; Yoo YB; Yang JH; Yun IJ
Cancer Inform; 2020; 19():1176935120969696. PubMed ID: 33223820
[TBL] [Abstract][Full Text] [Related]
33. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
34. LGR5 overexpression confers poor relapse-free survival in breast cancer patients.
Hou MF; Chen PM; Chu PY
BMC Cancer; 2018 Feb; 18(1):219. PubMed ID: 29471794
[TBL] [Abstract][Full Text] [Related]
35. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features and pituitary homeobox 1 gene expression in the progression and prognosis of cutaneous malignant melanoma.
Barut F; Udul P; Kokturk F; Kandemir NO; Keser SH; Ozdamar SO
Kaohsiung J Med Sci; 2016 Oct; 32(10):494-500. PubMed ID: 27742032
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of
Lyu L; Wang M; Zheng Y; Tian T; Deng Y; Xu P; Lin S; Yang S; Zhou L; Hao Q; Wu Y; Dai Z; Kang H
Cancer Manag Res; 2020; 12():12457-12471. PubMed ID: 33299353
[TBL] [Abstract][Full Text] [Related]
38. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
40. The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
Narbe U; Sjöström M; Forsare C; Bendahl PO; Alkner S; Leeb-Lundberg LMF; Lövgren K; Rydén L; Ingvar C; Fernö M
Breast Cancer Res Treat; 2019 Jun; 175(2):305-316. PubMed ID: 30796653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
